ATKINSON EDWARD MORROW III (EVP, Chief Technical Ops. Off.) sold 12.9% of their position (2.50K shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $1.09M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/19/2025ACC: 0000875320-25-000236
Officer· EVP, Chief Technical Ops. Off.
Since Feb 2026
-2.50K
Net shares
Net seller
$1.09M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.50K
Price / share
$434.58
Trade value
$1.09M
% of position
12.9%
11/17/2025
19.35K→16.85K
Total
Net shares
−2.50K
Net value
-$1.09M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/17/2025 | S · Sale | −2.50K | $434.58 | $1.09M | 12.9% | 19.35K | 16.85K |
| Total | −2.50K | -$1.09M | ||||||
Derivative Transactions0
No derivative transactions reported